Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK EUR

Nexus AG (NXUD.XC)

68.60
0.00
(0.00%)
At close: December 12 at 1:50:48 PM GMT
Loading Chart for NXUD.XC
  • Previous Close 68.60
  • Open 68.60
  • Bid --
  • Ask --
  • Day's Range 68.60 - 68.60
  • 52 Week Range 60.70 - 68.70
  • Volume 324
  • Avg. Volume 0
  • Market Cap (intraday) 1.2B
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 38.32
  • EPS (TTM) 1.79
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 0.22 (0.32%)
  • Ex-Dividend Date May 23, 2025
  • 1y Target Est --

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics. The company also provides human genetics, molecular pathology, HBOC, specialized laboratories, special diagnostics, gynecological hospital, ophthalmology, advanced reporting, MARIS healthcare GmbH, and ViREQ software solutions GmbH solutions for diagnostics. In addition, it offers radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions. Further, the company provides pathology, cytology, and laboratory solutions, as well as IT services comprising integrated solutions. NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany. As of January 3, 2025, Nexus AG was taken private.

www.nexus-ag.de

1,909

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NXUD.XC

View More

Performance Overview: NXUD.XC

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

NXUD.XC
0.00%
DAX P (^GDAXI)
13.00%

1-Year Return

NXUD.XC
13.43%
DAX P (^GDAXI)
25.46%

3-Year Return

NXUD.XC
29.22%
DAX P (^GDAXI)
59.58%

5-Year Return

NXUD.XC
99.00%
DAX P (^GDAXI)
107.12%

Compare To: NXUD.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NXUD.XC

View More

Valuation Measures

Annual
As of 3/11/2025
  • Market Cap

    1.22B

  • Enterprise Value

    1.12B

  • Trailing P/E

    38.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.53

  • Price/Book (mrq)

    4.24

  • Enterprise Value/Revenue

    4.22

  • Enterprise Value/EBITDA

    17.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.61%

  • Return on Assets (ttm)

    4.88%

  • Return on Equity (ttm)

    11.51%

  • Revenue (ttm)

    265.52M

  • Net Income Avi to Common (ttm)

    30.82M

  • Diluted EPS (ttm)

    1.79

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    116.37M

  • Total Debt/Equity (mrq)

    7.39%

  • Levered Free Cash Flow (ttm)

    27.67M

Research Analysis: NXUD.XC

View More

Company Insights: NXUD.XC

Research Reports: NXUD.XC

View More
Waiting for permission
Allow microphone access to enable voice search

Try again.